Increasing Rheumatoid Arthritis Prevalence Boosting Injectable Drug Market
Growing prevalence of chronic diseases including diabetes, rheumatoid arthritis significantly provides opportunities for growth of injectable market across UK. High demand of drugs for such diseases has provided immense opportunities to players to create their foothold in this injectable business. Moreover, giant pharmaceutical players have been competing with small pharma companies to maintain their share. Even scientists have been involved in promising research for providing novel injectables for rheumatoid arthritis. For example: a new injectable Mavrilimumab has come up with...
View full press release